CRISPR/CAS9敲除PD-1的肿瘤浸润T淋巴细胞回输对小鼠结肠癌的治疗作用  

Therapeutic effect of reinfusion of tumor-infiltrating lymphocyte with CRISPR/CAS9 knockout PD-1 on colon cancer in mice

作　　者：瞿紫微[1] 李晓辉[1] 郭建辉 陈华涛[1] 吴彪[1] 孟庆彬[1] QU Ziwei;LI Xiaohui;GUO Jianhui;CHEN Huatao;WU Biao;MENG Qingbin(Department of Gastrointestinal Surgery,the First Hospital of Wuhan,Wuhan 430022,China)

机构地区：[1]武汉市第一医院胃肠外科,武汉430022

出　　处：《中国免疫学杂志》2024年第6期1189-1196,共8页Chinese Journal of Immunology

基　　金：武汉市卫健委医学科研项目(WX21A11)。

摘　　要：目的:探讨应用成簇规律间隔的短回文重复序列及其相关蛋白(CRISPR/Cas9)技术敲除程序性死亡分子-1(PD-1)的肿瘤浸润淋巴细胞(TIL)回输对结肠癌小鼠的治疗作用。方法:皮下注射CT26构建小鼠结肠癌模型,从3只模型小鼠肿瘤组织中提取TIL,并提取外周血淋巴细胞;对TIL进行PD-1基因敲除;回输实验分为对照组(Control)、输注淋巴细胞组(Lym)、输注荷瘤小鼠TIL组(TIL)、慢病毒空载对照组(pVSV-G-PX458-NC)组、PX458-PD-1-sgRNA1组(PD-1-sgRNA1),每组10只;测量各组小鼠肿瘤组织质量及肿瘤抑制率;TUNEL法检测各组小鼠肿瘤组织细胞凋亡;ELISA检测各组小鼠肿瘤组织TNF-α和IFN-γ含量;免疫组化检测肿瘤组织CD4+T、CD8+T细胞表达;免疫荧光法检测肿瘤组织细胞增殖核抗原-67(Ki-67)和血管内皮生长因子(VEGF)表达;Western blot检测肿瘤组织PD-1及其主要配体PD-L1表达。结果:PD-1-sgRNA1能明显抑制小鼠肿瘤细胞体内生长,抑制肿瘤组织Ki-67和VEGF表达及PD-1、PD-L1表达,提高肿瘤组织细胞凋亡率、TNF-α、IFN-γ含量、CD4+T、CD8+T细胞表达(均P<0.05)。结论:CRISPR/CAS9敲除PD-1的TIL回输能明显抑制结肠癌小鼠肿瘤组织Ki-67和VEGF表达,增加CD4+T、CD8+T细胞,诱导肿瘤细胞凋亡,发挥抑制肿瘤生长作用。Objective:To investigate therapeutic effect of reinfusion of tumor-infiltrating lymphocyte(TIL)with clustered regularly interspaced short palindromic repeats/CRISPR-associated 9(CRISPR/CAS9)knockout programmed death-1(PD-1)on colon cancer in mice.Methods:Subcutaneous injection of CT26 was used to establish mouse colon cancer model.TIL was extracted from tumor tissue of three model mice,and peripheral blood lymphocytes were extracted.PD-1 gene was knocked out of TIL.Reinfusion experiments were divided into control group(Control),lymphocyte group(Lym),tumor-bearing mouse TIL group(TIL),lentivirus empty empty group(pVSV-G-PX458-NC)and PX458-PD-1-sgRNA1 group(PD-1-sgRNA1),with 10 mice in each group.Tumor tissue quality and tumor inhibition rate were detected in each group.TUNEL was used to detect cell apoptosis in tumor tissues of mice.ELISA was used to detect contents of TNF-αand IFN-γin tumor tissues of mice.Immunohistochemistry was used to detect expressions of CD4+T and CD8+T cells in tumor tissue.Immunofluorescence was used to detect expressions of proliferating cell nuclear antigen-67(Ki-67)and vascular endothelial growth factor(VEGF).Western blot was used to detect expressions of PD-1 and its ligand PD-L1 in tumor tissues.Results:PD-1-sgRNA1 could significantly inhibit growth of mouse tumor cells in vivo,inhibit expressions of Ki-67 and VEGF in tumor tissues,as well as expressions of PD-1 and PD-L1,elevate apoptosis rate,contents of TNF-αand IFN-γin tumor tissues,and expressions of CD4+T and CD8+T cells(all P<0.05).Conclusion:Reinfusion of TIL with CRISPR/CAS9 knockout PD-1 can significantly inhibit expressions of Ki-67 and VEGF in colon cancer mice,enhance infiltration of CD4+Tand CD8+T cells,induce tumor cell apoptosis and inhibit tumor growth.

关 键 词：CRISPR/Cas9 PD-1 结肠癌 肿瘤浸润淋巴细胞 肿瘤生长 

分 类 号：R735.3[医药卫生—肿瘤]